ask="6.29"
ask_size="100"
average_daily_volume="443506"
bid="3.47"
bid_size="900"
book_value="3.74"
change="+0.07"
change_from_200_day_moving_average="1.51"
change_from_50_day_moving_average="-1.17"
change_from_52_week_high="-7.26"
change_From_52_week_low="0.23"
change_in_percent="+1.92%"
close="3.72"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.37"
ebitda="-41.42M"
eps_estimate_current_year="5.02"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.03"
ex_dividend_date="N/A"
float_shares="13385000"
high="3.84"
high_52_weeks="10.98"
last_trade_date="1/24/2017"
last_trade_price="3.72"
last_trade_size="250122"
last_trade_time="4:00pm"
low="3.49"
low_52_weeks="3.49"
market_capitalization="83.89M"
moving_average_200_day="2.21"
moving_average_50_day="4.89"
name="Cascadian Therapeutics
Inc."
notes="N/A"
one_year_target_price="390.00"
open="3.49"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+68.30%"
percent_change_from_50_day_moving_average="-23.97%"
percent_change_from_52_week_high="-66.12%"
percent_change_from_52_week_low="+6.59%"
previous_close="3.65"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.98"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="22551000"
short_ratio="4.04"
stock_exchange="NMS"
symbol="CASC"
volume="4123544"
weeks_range_52="3.49 - 10.98"
